Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg given for 24 days compared to a 21-day regimen.

被引：0
|
作者：
Ellman, H
Archer, DF
机构：
[1] CONRAD Clin Res Ctr, Norfolk, VA USA
[2] Warner Chilcott, Rockaway, NJ USA
来源：
FERTILITY AND STERILITY | 2005年 / 84卷
关键词：
D O I：
10.1016/j.fertnstert.2005.07.420
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S169 / S170
页数：2
相关论文
共 36 条
  • [1] Bleeding profile of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg compared to a 21-day regimen.
    Ellman, H
    Archer, DF
    FERTILITY AND STERILITY, 2005, 84 : S171 - S171
  • [2] Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg (Loestrin® 24 Fe)
    Nakajima, Steven T.
    Archer, David F.
    Ellman, Herman
    CONTRACEPTION, 2007, 75 (01) : 16 - 22
  • [3] Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 μg/ethinylestradiol 15 μg and a 21-day regimen of desogestrel 150 μg/ethinylestradiol 20 μg
    Affronti, G.
    Spiclinann, D.
    Ambrosini, A.
    Bocci, A.
    Campogrande, M.
    Dodero, D.
    Flamigni, C.
    Giardina, G.
    Litta, P.
    Massobrio, M.
    Scarselli, G.
    Meriggi, E.
    Pauwels, C. P.
    DeBruyn, M.
    Gerris, J.
    Nolens, J. P.
    Blanchere, J. P.
    Bernard-Besnoit, A.
    Bilhaut, J. P.
    Coudray, J.
    Guigues, B.
    Jolly, C.
    Maupain, M.
    Hieu, N. Nguyen
    Amadio, E.
    Dalbos, D.
    De Granvilliers, M. A.
    Devaure, Y.
    De Vedrine, C. H.
    Dress, M. M.
    Guibert, L.
    Hazane, J. C.
    Kern, A. M.
    Levrier, M.
    Malgouyat, J.
    Mallet, F.
    Marteau, C.
    Safayan, A.
    Sentenac, J.
    De Boer, R.
    Van Enk, A.
    Mattheussens, O. J. A.
    The, H. S.
    Ypma, T. J. D.
    Rickli, J. P.
    Florek, E.
    Stadlin, M.
    Bitzer, J.
    Brunclik, V.
    Grueter, J.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 1999, 4 : 17 - 25
  • [4] Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity
    Sullivan, H
    Furniss, H
    Spona, J
    Elstein, M
    FERTILITY AND STERILITY, 1999, 72 (01) : 115 - 120
  • [5] Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel
    Endrikat, J
    Cronin, M
    Gerlinger, C
    Ruebig, A
    Schmidt, W
    Düsterberg, B
    CONTRACEPTION, 2001, 64 (03) : 201 - 207
  • [6] Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill A Randomized Controlled Trial
    Kaunitz, Andrew M.
    Burkman, Ronald T.
    Fisher, Alan C.
    LaGuardia, Katherine D.
    OBSTETRICS AND GYNECOLOGY, 2009, 114 (06): : 1205 - 1212
  • [7] Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill: A Randomized Controlled Trial
    Richman, Susan
    OBSTETRICS AND GYNECOLOGY, 2010, 115 (04): : 866 - 867
  • [8] The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 μg and ethinylestradiol 15 μg
    Bocci, A.
    Spielniann, D.
    Azzini, Pr
    Guaschino, Pr
    Affronti, G.
    Villani, Pr
    Boselli, Pr
    Genazzani, Pr
    Flamigni, Z. C.
    Omodei, U.
    Bolis, P.
    Marsoni, V.
    Luerti, M.
    Simenel, J. L.
    Ouvry-Neveu, B.
    Andre, G.
    David, S.
    Durand, J. L.
    Ehret-Mentre, C.
    Gensburger, J. M.
    Goetzmann, P.
    Jung-Faerber, S.
    Keller, D.
    Lempereur, M.
    Plumere, C.
    Spielmann, A.
    Katz, J. L.
    Sebaoun, J.
    Belaisch, J.
    Hammer, F.
    Salama, B.
    Aissaoui, S.
    Taube, A. M.
    Nakache, H.
    Soria, J.
    Joffo, M.
    Lardenois, H.
    Leclerc, P.
    Ponsar, C.
    Saubry-Bobet, V.
    Blaiset, E.
    Veyres, F.
    Clamp, M.
    Menon, K. V. K.
    Moran, D. G.
    Randall, S.
    Shaw, P. J.
    Bruni, V.
    Massobrio, M.
    Crosignani, P.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 1999, 4 : 9 - 15
  • [9] Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study
    Christin-Maitre, S.
    Serfaty, D.
    Chabbert-Buffet, N.
    Ochsenbein, E.
    Chassard, D.
    Thomas, J. -L.
    HUMAN REPRODUCTION, 2011, 26 (06) : 1338 - 1347
  • [10] The Risk of VTE in Users of a 24-Day Regimen of a Combined Oral Contraceptive Compared to Conventional 21-Day OC Regimens: Results from the INAS-OC Study
    Dinger, Juergen
    Bardenheuer, Kristina
    Franke, Christian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S131 - S131
1234